Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11702471 IL-1β neutralizing human monoclonal antibodies

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Agency for Science, Technology and Research

0

Current Assignee

Agency for Science, Technology and Research

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 18, 2023

0

Patent Application Number

171506910

Date Filed

January 15, 2021

0

Patent Citations

US Patent 7608694 Antibody molecules having specificity for human IL-1β

0

US Patent 7695717 Method of treating an IL-1 related inflammatory disease or condition

0

US Patent 7714120 Humanized anti-IL-1 beta antibodies

0

US Patent 7744865 IL1-β Binding antibodies and fragments thereof

0

US Patent 7744866 IL-1β binding antibodies and binding fragments thereof

0

US Patent 7829093 Method of treating an IL-1 related autoimmune disease or condition

0

US Patent 7829094 Method of treating an IL-1 related cancer

0

US Patent 7943121 IL-1β binding antibodies and fragments thereof

0

...

Patent Primary Examiner

0

CPC Code

0

0

The present invention is directed to antigen binding proteins and in particular to IL-1β antigen binding proteins. The present invention further provides compositions comprising the antigen binding proteins, use of the antigen binding proteins and methods for production.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11702471 IL-1β neutralizing human monoclonal antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool